Pharsight

Genzyme patents expiration

1. Mozobil patents expiration

MOZOBIL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7897590 GENZYME Methods to mobilize progenitor/stem cells
Jul, 2023

(7 months ago)

US6987102 GENZYME Methods to mobilize progenitor/stem cells
Jul, 2023

(7 months ago)

Drugs and Companies using PLERIXAFOR ingredient

Market Authorisation Date: 15 December, 2008

Treatment: Use in combination with granulocyte-colony stimulating factor (g-csf) to mobilize hematopoietic stem cells to peripheral blood for collection & subsequent autologous transplantation in patients with n...

Dosage: SOLUTION;SUBCUTANEOUS

How can I launch a generic of MOZOBIL before it's drug patent expiration?
More Information on Dosage

MOZOBIL family patents

Family Patents

2. Renvela patents expiration

RENVELA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9095509 GENZYME Sachet formulation for amine polymers
Dec, 2030

(6 years from now)

Drugs and Companies using SEVELAMER CARBONATE ingredient

Market Authorisation Date: 18 February, 2009

Treatment: NA

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of RENVELA before it's drug patent expiration?
More Information on Dosage

RENVELA family patents

Family Patents